Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

The Preventive Role of Gemfibrozil on Bleomycin-Induced Lung Injury and Fibrosis in Rats

Yasna Mohammadi 1 , 2 , Mohammad Javad Khodayar 2 , 3 , * , Aliasghar Hemmati 4 and Esrafil Mansouri 5
Authors Information
1 Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Faculty of Allied Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Department of Toxicology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4 Department of Pharmacology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5 Department of Anatomical Sciences, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: 12 (3 (Supp)); e64314
  • Published Online: August 31, 2017
  • Article Type: Research Article
  • Received: February 12, 2016
  • Revised: January 8, 2017
  • Accepted: February 19, 2017
  • DOI: 10.5812/jjnpp.64314

To Cite: Mohammadi Y, Khodayar M J, Hemmati A, Mansouri E. The Preventive Role of Gemfibrozil on Bleomycin-Induced Lung Injury and Fibrosis in Rats, Jundishapur J Nat Pharm Prod. Online ahead of Print ; 12(3 (Supp)):e64314. doi: 10.5812/jjnpp.64314.

Copyright © 2017, Jundishapur Journal of Natural Pharmaceutical Products. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Craig VJ, Quintero PA, Fyfe SE, Patel AS, Knolle MD, Kobzik L, et al. Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury. J Immunol. 2013; 190(8): 4283-96[DOI][PubMed]
  • 2. Travis WD, Costabel U, Hansell DM, King TJ, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013; 188(6): 733-48[DOI][PubMed]
  • 3. Kim DS, Collard HR, King TJ. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc. 2006; 3(4): 285-92[DOI][PubMed]
  • 4. Lasky JA, Ortiz LA, Tonthat B, Hoyle GW, Corti M, Athas G, et al. Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am J Physiol. 1998; 275(2 Pt 1)-71[PubMed]
  • 5. Punithavathi D, Venkatesan N, Babu M. Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. Br J Pharmacol. 2003; 139(7): 1342-50[DOI][PubMed]
  • 6. Kuwano K, Kunitake R, Maeyama T, Hagimoto N, Kawasaki M, Matsuba T, et al. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol. 2001; 280(2)-25[PubMed]
  • 7. Santana A, Saxena B, Noble NA, Gold LI, Marshall BC. Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 1995; 13(1): 34-44[DOI][PubMed]
  • 8. Khalil N, Parekh TV, O'Connor RN, Gold LI. Differential expression of transforming growth factor-beta type I and II receptors by pulmonary cells in bleomycin-induced lung injury: correlation with repair and fibrosis. Exp Lung Res. 2002; 28(3): 233-50[DOI][PubMed]
  • 9. Smith RE, Strieter RM, Phan SH, Lukacs NW, Huffnagle GB, Wilke CA, et al. Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injury. J Immunol. 1994; 153(10): 4704-12[PubMed]
  • 10. Fujita M, Shannon JM, Irvin CG, Fagan KA, Cool C, Augustin A, et al. Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2001; 280(1)-49[PubMed]
  • 12. Oury TD, Thakker K, Menache M, Chang LY, Crapo JD, Day BJ. Attenuation of bleomycin-induced pulmonary fibrosis by a catalytic antioxidant metalloporphyrin. Am J Respir Cell Mol Biol. 2001; 25(2): 164-9[DOI][PubMed]
  • 13. Kinnula VL, Crapo JD, Raivio KO. Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest. 1995; 73(1): 3-19[PubMed]
  • 14. Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol. 2008; 40(3): 362-82[DOI][PubMed]
  • 15. Zhou C, Han W, Zhang P, Cai M, Wei D, Zhang C. Lycopene from tomatoes partially alleviates the bleomycin-induced experimental pulmonary fibrosis in rats. Nutr Res. 2008; 28(2): 122-30[DOI][PubMed]
  • 16. Lakatos HF, Thatcher TH, Kottmann RM, Garcia TM, Phipps RP, Sime PJ. The Role of PPARs in Lung Fibrosis. PPAR Res. 2007; 2007: 71323[DOI][PubMed]
  • 17. Camara-Lemarroy CR, Guzman DF, Cordero-Perez P, Ibarra-Hernandez JM, Munoz-Espinosa LE, Fernandez-Garza NE. Gemfibrozil attenuates the inflammatory response and protects rats from abdominal sepsis. Exp Ther Med. 2015; 9(3): 1018-22[DOI][PubMed]
  • 18. Feng X, Gao X, Jia Y, Zhang H, Xu Y, Wang G. PPAR-alpha Agonist Fenofibrate Decreased RANTES Levels in Type 2 Diabetes Patients with Hypertriglyceridemia. Med Sci Monit. 2016; 22: 743-51[DOI][PubMed]
  • 19. Sharma AK, Raikwar SK, Kurmi MK, Srinivasan BP. Gemfibrozil and its combination with metformin on pleiotropic effect on IL-10 and adiponectin and anti-atherogenic treatment in insulin resistant type 2 diabetes mellitus rats. Inflammopharmacology. 2013; 21(2): 137-45[DOI][PubMed]
  • 20. Roy A, Pahan K. Gemfibrozil, stretching arms beyond lipid lowering. Immunopharmacol Immunotoxicol. 2009; 31(3): 339-51[DOI][PubMed]
  • 21. Zhao SP, Ye HJ, Zhou HN, Nie S, Li QZ. Gemfibrozil reduces release of tumor necrosis factor-alpha in peripheral blood mononuclear cells from healthy subjects and patients with coronary heart disease. Clin Chim Acta. 2003; 332(1-2): 61-7[DOI][PubMed]
  • 22. Mohagheghi F, Khalaj L, Ahmadiani A, Rahmani B. Gemfibrozil pretreatment affecting antioxidant defense system and inflammatory, but not Nrf-2 signaling pathways resulted in female neuroprotection and male neurotoxicity in the rat models of global cerebral ischemia-reperfusion. Neurotox Res. 2013; 23(3): 225-37[DOI][PubMed]
  • 23. Schraufnagel DE, Mehta D, Harshbarger R, Treviranus K, Wang NS. Capillary remodeling in bleomycin-induced pulmonary fibrosis. Am J Pathol. 1986; 125(1): 97-106[PubMed]
  • 24. Szapiel SV, Elson NA, Fulmer JD, Hunninghake GW, Crystal RG. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis. 1979; 120(4): 893-9[DOI][PubMed]
  • 25. Bahrami-Karkevandi M, Moshtaghian SJ, Mahzoni P, Adibi S, Kazemi S. The effects of hydroalcoholic extract of Artemisia Aucheri on bleomycin induced pulmonary fibrosis in rats [In Persian]. J Shahrekord Univ Med Sci. 2011; 12(4): 33-40
  • 26. Tryka AF, Godleski JJ, Skornik WA, Brain JD. Progressive pulmonary fibrosis in hamsters. Exp Lung Res. 1983; 5(3): 155-71[DOI][PubMed]
  • 27. Idell S, James KK, Gillies C, Fair DS, Thrall RS. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am J Pathol. 1989; 135(2): 387-99[PubMed]
  • 28. Schrier DJ, Phan SH, McGarry BM. The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis. A biochemical evaluation. Am Rev Respir Dis. 1983; 127(5): 614-7[DOI][PubMed]
  • 29. Chandler DB, Hyde DM, Giri SN. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am J Pathol. 1983; 112(2): 170-7[PubMed]
  • 30. Giri SN, Hyde DM, Braun RK, Gaarde W, Harper JR, Pierschbacher MD. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol. 1997; 54(11): 1205-16[DOI][PubMed]
  • 31. Zhao J, Shi W, Wang YL, Chen H, Bringas PJ, Datto MB, et al. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol. 2002; 282(3)-93[DOI][PubMed]
  • 32. Ozyurt H, Sogut S, Yildirim Z, Kart L, Iraz M, Armutcu F, et al. Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clin Chim Acta. 2004; 339(1-2): 65-75[DOI][PubMed]
  • 33. Card JW, Racz WJ, Brien JF, Massey TE. Attenuation of amiodarone-induced pulmonary fibrosis by vitamin E is associated with suppression of transforming growth factor-beta1 gene expression but not prevention of mitochondrial dysfunction. J Pharmacol Exp Ther. 2003; 304(1): 277-83[DOI][PubMed]
  • 34. Henson PM, Johnston RJ. Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J Clin Invest. 1987; 79(3): 669-74[DOI][PubMed]
  • 35. Fantone JC, Phan SH. Oxygen metabolite detoxifying enzyme levels in bleomycin-induced fibrotic lungs. Free Radic Biol Med. 1988; 4(6): 399-402[DOI][PubMed]
  • 36. Asgary S, Dinani NJ, Madani H, Mahzouni P. Ethanolic extract of Artemisia aucheri induces regression of aorta wall fatty streaks in hypercholesterolemic rabbits. Pharmazie. 2008; 63(5): 394-7[PubMed]
  • 37. Farzaneh M, Ahmadzadeh M, Hadian J, Tehrani AS. Chemical composition and antifungal activity of the essential oils of three species of Artemisia on some soil-borne phytopathogens. Commun Agric Appl Biol Sci. 2006; 71(3 Pt B): 1327-33[PubMed]
  • 38. Zhou G, Niu JZ, Wang JF, Chen WT, Liu TX, Li YS, et al. [Experimental study on effect of curcumin on inhibiting injury of free radical in pulmonary fibrosis rats]. Zhongguo Zhong Yao Za Zhi. 2006; 31(8): 669-72[PubMed]
  • 39. Kim HR, Park BK, Oh YM, Lee YS, Lee DS, Kim HK, et al. Green tea extract inhibits paraquat-induced pulmonary fibrosis by suppression of oxidative stress and endothelin-l expression. Lung. 2006; 184(5): 287-95[DOI][PubMed]
  • 40. Karaman M, Özen H, Dağ, S. , Atakİşİ, O. . Ameliorative effect of omega-3 in carbon tetrachloride toxicity. Kafkas Univ Vet Fak Derg. 2017; 23(1): 77-85
  • 41. Despres JP, Lemieux I, Pascot A, Almeras N, Dumont M, Nadeau A, et al. Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2003; 23(4): 702-3[DOI][PubMed]
  • 42. Calkin AC, Cooper ME, Jandeleit-Dahm KA, Allen TJ. Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation. Diabetologia. 2006; 49(4): 766-74[DOI][PubMed]
  • 43. Jana M, Jana A, Liu X, Ghosh S, Pahan K. Involvement of phosphatidylinositol 3-kinase-mediated up-regulation of I kappa B alpha in anti-inflammatory effect of gemfibrozil in microglia. J Immunol. 2007; 179(6): 4142-52[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments